1. Home
  2. PHAR vs PRSU Comparison

PHAR vs PRSU Comparison

Compare PHAR & PRSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$16.60

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Pursuit Attractions and Hospitality Inc.

PRSU

Pursuit Attractions and Hospitality Inc.

HOLD

Current Price

$39.52

Market Cap

946.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHAR
PRSU
Founded
1988
1926
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
946.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PHAR
PRSU
Price
$16.60
$39.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$39.00
$31.67
AVG Volume (30 Days)
17.7K
210.1K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.04
$4.85
Revenue Next Year
$2.51
$4.94
P/E Ratio
$3,041.22
$3.45
Revenue Growth
N/A
N/A
52 Week Low
$7.79
$26.90
52 Week High
$21.34
$38.93

Technical Indicators

Market Signals
Indicator
PHAR
PRSU
Relative Strength Index (RSI) 55.12 65.16
Support Level $16.55 $32.90
Resistance Level $17.60 N/A
Average True Range (ATR) 0.61 1.25
MACD 0.15 0.37
Stochastic Oscillator 81.86 96.76

Price Performance

Historical Comparison
PHAR
PRSU

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

About PRSU Pursuit Attractions and Hospitality Inc.

Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, and Iceland. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.

Share on Social Networks: